January 19th, 2022
JEFF BARNES EXTENDS RELATIONSHIP WITH FREMEDICA TECHNOLOGIES AS CHIEF MARKETING OFFICER
November 3rd, 2022
FREMEDICA LAUNCHES NIGHT-TIME WEARABLE THAT IMPROVES CELLULAR FUNCTION FOR BETTER SLEEP, LESS PAIN AND MORE ENERGY
October 27th, 2022
FREMEDICA LAUNCHES NIGHT-TIME WEARABLE THAT IMPROVES CELLULAR FUNCTION FOR BETTER SLEEP, LESS PAIN AND MORE ENERGY
October 6th, 2022
FREQUENCY EXCHANGE’S SUBSIDIARY ANNOUNCES FIRST SHIPMENT OF NIKKIS SCHEDULED TO ARRIVE IN CANADA IN NOVEMBER
September 14th, 2022
FREQUENCY EXCHANGE’S SUBSIDIARY ANNOUNCES SIGNIFICANT PROOF OF CONCEPT TRIAL RESULTS
September 12th, 2022
FREQUENCY EXCHANGE ANNOUNCES CHANGES IN MANAGEMENT AND BOARD OF DIRECTORS
August 23rd, 2022
FREQUENCY EXCHANGE’S SUBSIDIARY RECEIVES CERTIFICATIONS FOR NIKKI WEARABLE
July 26th, 2022
FREQUENCY EXCHANGE CORP ENGAGES GLOBALLY RENOWNED FREQUENCY DOCTOR TEAM
July 18th, 2022
FREQUENCY EXCHANGE’S SUBSIDIARY ENTERS INTO LICENSING AND DEVELOPMENT AGREEMENT WITH WAREHOUSE
April 21st, 2022
FREQUENCY EXCHANGE CORP ANNOUNCES GLOBAL BUSINESS EXPANSION INTO GENERAL HEALTH AND WELLNESS
February 8th, 2022
FREQUENCY EXCHANGE CORP ENGAGES PARADOX PUBLIC RELATIONS INC. AND GRANTS STOCK OPTIONS.
February 7th, 2022
FREQUENCY EXCHANGE CORP. (FORMERLY ISRAEL CAPITAL CANADA CORP.) COMPLETES QUALIFYING TRANSACTION AND NAME CHANGE; WILL COMMENCE TRADING UNDER “FREQ”.
February 2nd, 2022
FREQUENCY EXCHANGE CORP. COMMENCES TRADING ON TSX VENTURE EX-CHANGE UNDER “FREQ” FOLLOWING COMPLETION OF QUALIFYING TRANSACTION.